Shtam T A, Pantina R A, Varfolomeeva E Iu, Filatov M V
Vopr Onkol. 2007;53(2):194-9.
The study was concerned with identification of predictive value of p53 expression on sensitivity to tamoxifen in breast cancer management. Estrogen receptor-positive cell line MCF-7 was used to establish p53 expression influence on the rate of cell proliferation after tamoxifen. The investigation demonstrated the absence of that effect when p53 was silenced.
该研究关注于确定p53表达对乳腺癌治疗中他莫昔芬敏感性的预测价值。雌激素受体阳性细胞系MCF-7被用于确定p53表达对他莫昔芬作用后细胞增殖速率的影响。研究表明,当p53沉默时,不存在这种影响。